primary hyperparathyroidism
Showing 1 - 25 of 55
Parathyroid Tumor Clonal Status
Active, not recruiting
- Parathyroid Tumor
- Primary Hyperparathyroidism
-
Birmingham, Alabama
- +2 more
Aug 11, 2023
Glycemic Control, Type II Diabetes, Parathyroidectomy
Recruiting
- Primary Hyperparathyroidism
- Type 2 Diabetes
- Urine and Blood Test
-
Cleveland, OhioCleveland Clinic Main Campus
Feb 28, 2023
Primary Hyperparathyroidism Trial in Bern
Completed
- Primary Hyperparathyroidism
-
Bern, SwitzerlandDepartment of visceral surgery and transplant surgery, Berne Uni
Jan 24, 2023
Natural History Study of Parathyroid Disorders
Recruiting
- Parathyroid Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Parathyroid Adenoma, Parathyroid Tumors, Parathyroid Hyperplasia Trial in Nashville (NIRAF Detection Technology)
Active, not recruiting
- Parathyroid Adenoma
- +5 more
- NIRAF Detection Technology
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 19, 2022
Primary Hyperparathyroidism, Thyroid Disease, Parathyroid Diseases Trial in Ostrava (Conventional (dual-phase) SPECT/CT,
Completed
- Primary Hyperparathyroidism
- +3 more
- Conventional (dual-phase) SPECT/CT
- +3 more
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Dec 6, 2022
Impact of Parathyroidectomy on Renal Function
Recruiting
- Primary Hyperparathyroidism
- parathyroidectomy
-
Vandœuvre-lès-Nancy, Lorraine, FranceCHRU Nancy
Dec 2, 2022
Primary Hyperparathyroidism, Osteoporosis Trial in Ljubljana (Denosumab 60 MG/ML Prefilled Syringe [Prolia], Zoledronic Acid)
Enrolling by invitation
- Primary Hyperparathyroidism
- Osteoporosis
- Denosumab 60 MG/ML Prefilled Syringe [Prolia]
- Zoledronic Acid
-
Ljubljana, SloveniaEndocrinology Department
Nov 2, 2022
Primary Hyperparathyroidism Trial in New York (Denosumab, Placebo)
Terminated
- Primary Hyperparathyroidism
- Denosumab
- Placebo
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022
Primary Hyperparathyroidism, Osteoporosis, Postmenopausal Trial in Philadelphia
Active, not recruiting
- Primary Hyperparathyroidism
- Osteoporosis, Postmenopausal
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine/ Hospital of the Universit
Sep 22, 2022
Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)
Completed
- Pituitary ACTH Hypersecretion
- +3 more
- Cholecalciferol 15000 UNT/ML Oral Solution
-
Moscow, Russian FederationEndocrinology Research Centre, Moscow
Aug 10, 2022
Cohort Primary Hyperparathyroidism
Recruiting
- Primary Hyperparathyroidism
-
Nantes, Loire-Atlantique, FranceNantes University Hospital
Jul 19, 2022
Mechanical Loading on vBMD and Geometry in Primary
Completed
- Primary Hyperparathyroidism
- (no location specified)
Jun 21, 2022
Primary Hyperparathyroidism Trial in Odense C (Contrast-enhanced ultrasound)
Completed
- Primary Hyperparathyroidism
- Contrast-enhanced ultrasound
-
Odense C, DenmarkOdense University Hospital
Apr 7, 2022
Primary Hyperparathyroidism Trial in Lund (Parathyroid surgery)
Recruiting
- Primary Hyperparathyroidism
- Parathyroid surgery
-
Lund, SwedenSkåne University Hospital, Department of Surgery, Lund
Feb 28, 2022
Parathyroid Adenoma, Parathyroid Tumors, Parathyroid Cancer Trial in Ann Arbor (PTeye)
Recruiting
- Parathyroid Adenoma
- +4 more
- PTeye
-
Ann Arbor, MichiganThe University of Michigan
Jan 5, 2022
Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)
Completed
- Primary Hyperparathyroidism
- eplerenone
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 26, 2021
Parathyroid Gland Adenoma, Primary Hyperparathyroidism Trial in Buffalo (Laboratory Biomarker Analysis, Parathyroidectomy)
Completed
- Parathyroid Gland Adenoma
- Primary Hyperparathyroidism
- Laboratory Biomarker Analysis
- Parathyroidectomy
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 9, 2021
Parathyroid Carcinoma, Primary Hyperparathyroidism Trial in Osaka (KHK7580)
Completed
- Parathyroid Carcinoma
- Primary Hyperparathyroidism
-
Ōsaka, JapanOsaka City University Hospital
May 26, 2021
Primary Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Hyperplasia Trial in Aalborg (Cinacalcet 30 mg Tablet, Denosumab
Completed
- Primary Hyperparathyroidism
- +2 more
- Cinacalcet 30 mg Tablet
- +3 more
-
Aalborg, DenmarkAalborg University Hospital
May 1, 2021
Primary Hyperparathyroidism Trial in Monserrato (Parahtyroidectomy)
Completed
- Primary Hyperparathyroidism
- Parahtyroidectomy
-
Monserrato, Cagliari, Italy
- +1 more
Feb 4, 2021
Diagnostic Performance of 11C-choline PET/CT in Primary
Completed
- Primary Hyperparathyroidism
- Primary Hyperparathyroidism Due to Adenoma
- 11C-choline PET/CT
- (no location specified)
Oct 27, 2020
Molecular and Immunohistochemical Profiling of Tumors in
Unknown status
- Parathyroid Gland Adenoma
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Jan 9, 2020
Baseline Bone Mineral Density After Parathyroidectomy in Primary
Unknown status
- Primary Hyperparathyroidism
- Retrospective Data Review
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 8, 2020
Primary Hyperparathyroidism Trial in Stockholm (Cinacalcet, parathyroid adenomectomy)
Unknown status
- Primary Hyperparathyroidism
- Cinacalcet
- parathyroid adenomectomy
-
Stockholm, SwedenKarolinska University Hospital
Jan 6, 2020